APT Medical Inc. (688617.SS) has a MoatMap StockRank of 66/100 based on Quality (90/100), Value (19/100), and Momentum (41/100) factor scores. The current signal is BUY. APT Medical is a premier Chinese medical device company with exceptional quality metrics (Q: 90). It is a prime beneficiary of China's domestic substitution policy in high-end medical consumables (electrophysiology). However, geopolitical risks and high domestic valuation prevent a high-conviction buy at this stage.
APT Medical Inc. is a leading developer and manufacturer of minimally invasive interventional medical devices, specializing in electrophysiology (EP) and vascular access. The company is a domestic pioneer in China's EP market, offering a comprehensive portfolio of diagnostic and ablation catheters that compete with multinational giants. Its competitive moat is sustained by proprietary manufacturing processes for micro-catheters and a strong clinical training network for cardiologists.
| Price | $29.41 |
| Market Cap | $4.3B |
| P/E (TTM) | 32.80 |
| P/E (Forward) | 22.27 |
| Price/Book | 9.47 |
| Return on Equity | 29.7% |
| Return on Invested Capital | 29.4% |
| Debt/Equity | 0.48 |
| Gross Margin | 72.5% |
| Operating Margin | 37.5% |
| Revenue Growth | 24.8% |
| Dividend Yield | 0.5% |
| Free Cash Flow | $8M |
APT Medical Inc. operates in the Medical Devices industry, part of the Healthcare sector (China).